AwesomeCapital
Search This Blog
Thursday, February 6, 2020
Pacific Biosciences of California EPS beats by $0.16, beats on revenue
Pacific Biosciences of California (NASDAQ:
PACB
): Q4 GAAP EPS of $0.00
beats by $0.16
.
Revenue of $27.93M (+43.0% Y/Y)
beats by $2.41M
.
Press Release
https://seekingalpha.com/news/3539400-pacific-biosciences-of-california-eps-beats-0_16-beats-on-revenue
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.